dijous, 13 de març del 2014

Merit Medical gets FDA's highest-risk label over Hospira injections




FDA regulators put their highest-risk label on Merit Medical's recall of kits containing 1% Lidocaine HCl injections manufactured by Hospira.





Merit Medical gets FDA's highest-risk label over Hospira injections



read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1oQHALF

Cap comentari:

Publica un comentari a l'entrada